At a glance
ClinicalIndex Comparison RecordN/ACompleted· 300 enrolled
Drug / intervention
Transcatheter Aortic Valve Implantation (TAVI)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PRospective Evaluation Complementing Investigation With Acurate Neo Device
In Brief
An observational study evaluating Transcatheter Aortic Valve Implantation (TAVI) for Aortic Stenosis. Completed, enrolled 300 participants across 10 sites.
Detailed Summary
The study collects real-world data of patients who were treated with the Acurate Neo TAVI System and evaluates early and midterm clinical outcomes.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Stenosis
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 2019
Enrollment StartMay 2019
Primary CompletionSep 2021
Study CompletionOct 2021
TodayJul 2026
First PostedFeb 19, 2019
Enrollment StartMay 20, 2019
Primary CompletionSep 2, 2021
Study CompletionOct 2, 2021
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 7.4 years ago
Interventions
Transcatheter Aortic Valve Implantation (TAVI)device
Implantation of the Acurate Neo Transcatheter Heart Valve